JP2010535829A5 - - Google Patents

Download PDF

Info

Publication number
JP2010535829A5
JP2010535829A5 JP2010520498A JP2010520498A JP2010535829A5 JP 2010535829 A5 JP2010535829 A5 JP 2010535829A5 JP 2010520498 A JP2010520498 A JP 2010520498A JP 2010520498 A JP2010520498 A JP 2010520498A JP 2010535829 A5 JP2010535829 A5 JP 2010535829A5
Authority
JP
Japan
Prior art keywords
ethylsulfonyl
naphthalen
polymorphs
oxazole
benzo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010520498A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010535829A (ja
Filing date
Publication date
Priority claimed from GBGB0715937.9A external-priority patent/GB0715937D0/en
Application filed filed Critical
Publication of JP2010535829A publication Critical patent/JP2010535829A/ja
Publication of JP2010535829A5 publication Critical patent/JP2010535829A5/ja
Pending legal-status Critical Current

Links

JP2010520498A 2007-08-15 2008-08-14 デュシェンヌ型筋ジストロフィーの治療用の化合物の多形体 Pending JP2010535829A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0715937.9A GB0715937D0 (en) 2007-08-15 2007-08-15 Method of treatment og duchenne muscular dystrophy
PCT/EP2008/006718 WO2009021748A2 (en) 2007-08-15 2008-08-14 Polymorphs of a compound for the treatment of duchenne muscular dystrophy

Publications (2)

Publication Number Publication Date
JP2010535829A JP2010535829A (ja) 2010-11-25
JP2010535829A5 true JP2010535829A5 (enExample) 2011-09-29

Family

ID=38566447

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010520498A Pending JP2010535829A (ja) 2007-08-15 2008-08-14 デュシェンヌ型筋ジストロフィーの治療用の化合物の多形体
JP2010520499A Pending JP2010535830A (ja) 2007-08-15 2008-08-14 デュシェンヌ型筋ジストロフィーの治療用化合物の製造

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010520499A Pending JP2010535830A (ja) 2007-08-15 2008-08-14 デュシェンヌ型筋ジストロフィーの治療用化合物の製造

Country Status (17)

Country Link
US (2) US20090048314A1 (enExample)
EP (2) EP2188270A2 (enExample)
JP (2) JP2010535829A (enExample)
KR (1) KR20100075777A (enExample)
CN (2) CN101679323A (enExample)
AR (1) AR068810A1 (enExample)
AU (2) AU2008286325A1 (enExample)
BR (2) BRPI0811548A2 (enExample)
CA (2) CA2685590A1 (enExample)
CL (1) CL2008002391A1 (enExample)
GB (1) GB0715937D0 (enExample)
IL (1) IL201908A0 (enExample)
MX (2) MX2009011967A (enExample)
PE (1) PE20090604A1 (enExample)
RU (1) RU2009141831A (enExample)
TW (1) TW200911767A (enExample)
WO (2) WO2009021749A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8518980B2 (en) * 2006-02-10 2013-08-27 Summit Corporation Plc Treatment of Duchenne muscular dystrophy
GB201208178D0 (en) 2012-05-10 2012-06-20 Summit Corp Plc Pharmaceutical composition for the treatment of duchenne muscular dystrophy
GB201412010D0 (en) 2014-07-04 2014-08-20 Summit Corp Plc Treatment of hypertransaminasemia
BR112018070076A2 (pt) * 2016-03-30 2019-05-21 Summit (Oxford) Limited composição para o tratamento de distrofia muscular de duchenne
WO2017175842A1 (ja) * 2016-04-07 2017-10-12 国立大学法人京都大学 スプライシングの改変に関する化合物及び医薬組成物
KR102019048B1 (ko) 2017-02-06 2019-09-09 가톨릭대학교 산학협력단 MG53과 Orai1의 결합을 이용한 근육긴장저하 치료제 스크리닝 방법
KR101886788B1 (ko) 2017-02-07 2018-08-09 가톨릭대학교 산학협력단 MG53과 Orai1의 결합을 이용한 뒤시엔느 골격근 위축증 치료제 스크리닝 방법
WO2018236879A1 (en) 2017-06-19 2018-12-27 University Of Maryland, Baltimore Microtubule polymerization inhibitor prodrugs and methods of using the same

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993659A (en) * 1971-08-10 1976-11-23 Ciba-Geigy Corporation Bis-benzoxazolyl-naphthalenes as optical brighteners
CH617809GA3 (enExample) * 1975-10-10 1980-06-30
US4110246A (en) * 1976-05-13 1978-08-29 Hoechst Aktiengesellschaft Mixture of benzoxazole derivatives
DE3027479A1 (de) * 1980-07-19 1982-03-04 Hoechst Ag, 6000 Frankfurt Mischungen von optischen aufhellern und deren verwendung
JPS615071A (ja) * 1984-06-15 1986-01-10 Fuji Photo Film Co Ltd ベンゾオキサゾ−ル誘導体
DE3617451A1 (de) * 1986-05-23 1987-11-26 Hoechst Ag Sulfonat- oder sulfonamidgruppen-haltige bis-benzoxazolylnaphthaline, verfahren zu deren herstellung und deren verwendung
DE3819051A1 (de) * 1988-06-04 1989-12-07 Agfa Gevaert Ag Farbfotografisches aufzeichnungsmaterial
ES2092080T3 (es) * 1991-08-08 1996-11-16 Ciba Geigy Ag Colorantes, procedimiento para su obtencion y su utilizacion.
ES2157268T5 (es) * 1994-02-24 2004-12-01 SYMRISE GMBH & CO KG Preparados cosmeticos y dermatologicos que contienen acidos fenilen-1,4-bisbencimidazolsulfonicos.
US6004719A (en) * 1994-04-25 1999-12-21 Polaroid Corporation Imaging medium and process for producing an image
BR9508177A (pt) * 1994-06-30 1997-09-02 Minnesota Mining & Mfg Material de impressão dental e processo para monitorar a cura do mesmo
US5583178A (en) * 1994-06-30 1996-12-10 Minnesota Mining And Manufacturing Company Cure-indicating molding and coating composition
US5567843A (en) * 1995-03-20 1996-10-22 The Dow Chemical Company Process for making 2-aryl benz (ox, thi, imid)azoles and 2-aminoaryl aminobenz(ox, thi, imid)azoles
US6222044B1 (en) * 1995-03-20 2001-04-24 The Dow Chemical Company Process for making 2-aryl benz (ox, thi, imid) azoles and 2-aminoaryl aminobenz (ox, thi, imid) azoles
US5977101A (en) * 1995-06-29 1999-11-02 Smithkline Beecham Corporation Benzimidazoles/Imidazoles Linked to a Fibrinogen Receptor Antagonist Template Having Vitronectin Receptor Antagonist Activity
US5645948A (en) * 1996-08-20 1997-07-08 Eastman Kodak Company Blue organic electroluminescent devices
US5914213A (en) * 1996-11-27 1999-06-22 Polaroid Corporation Process and composition for generation of acid
US6110638A (en) * 1996-11-27 2000-08-29 Polaroid Corporation Process and composition for generation of acid
US6177572B1 (en) * 1997-08-20 2001-01-23 Sepracor, Inc. Solid and liquid-phase synthesis of benzoxazoles and benzothiazoles and their use
US6312822B1 (en) * 1998-05-28 2001-11-06 Eastman Chem Co Dispersion aids for optical brighteners in polyolefins
GB9815880D0 (en) * 1998-07-21 1998-09-16 Pfizer Ltd Heterocycles
US6436558B1 (en) * 1998-08-07 2002-08-20 Fuji Photo Film Co., Ltd. Organic electroluminescence element
FR2789581B1 (fr) * 1999-02-12 2001-05-04 Oreal Compositions photoprotectrices contenant un derive de benzotriazole, un derive de bis-resorcinyl triazine et un compose a groupements benzoazolyle ou benzodiazolyle
FR2789582B1 (fr) * 1999-02-12 2001-05-04 Oreal Compositions photoprotectrices contenant un derive de bis-resorcinyl triazine et un compose a groupements benzoazolyle ou benzodiazolyle
AU4755600A (en) * 1999-05-07 2000-11-21 Basf Aktiengesellschaft Benzohetero cyclylcyclo hexenones and their use as herbicides
CA2373293A1 (en) * 1999-05-07 2000-11-16 Basf Aktiengesellschaft 4-(3',4'-heterocyclyl benzoyl) pyrazoles as herbicidal agents
FR2794645B1 (fr) * 1999-06-08 2001-08-10 Oreal Compositions photoprotectrices contenant un compose hydrocarbone bis-hydroxyphenylbenzotriazole et un compose a groupements benzoazolyle ou benzodiazolyle
DE60018194T2 (de) * 1999-09-24 2006-01-05 Ono Pharmaceutical Co. Ltd. Hydroxamsäurederivate, verfahren zu ihrer herstellung und medikamente die diese als aktiven wirkstoff enthalten
US6565987B2 (en) * 1999-11-12 2003-05-20 Eastman Chemical Company Non-exuding optically brightened polyolefin blends
US6716413B1 (en) * 2000-10-16 2004-04-06 Mallinckrodt, Inc. Indole compounds as tissue-specific exogenous optical agents
KR100865096B1 (ko) * 2000-11-30 2008-10-24 캐논 가부시끼가이샤 발광 소자 및 표시 장치
US20050113283A1 (en) * 2002-01-18 2005-05-26 David Solow-Cordero Methods of treating conditions associated with an EDG-4 receptor
US20050261298A1 (en) * 2002-01-18 2005-11-24 David Solow-Cordero Methods of treating conditions associated with an Edg-7 receptor
EP1482931B1 (en) * 2002-03-05 2011-10-19 TransTech Pharma, Inc. Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
US20050260126A1 (en) * 2002-08-30 2005-11-24 Yukitsuka Kudo Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein
WO2004110998A1 (en) * 2003-05-16 2004-12-23 Ambit Biosciences Corporation Pyrrole compounds and uses thereof
CN1805743A (zh) * 2003-05-20 2006-07-19 特兰斯泰克制药公司 用作逆转淀粉样变性及其他与之相关疾病的rage拮抗剂
MXPA06002853A (es) * 2003-09-11 2006-06-14 Kemia Inc Inhibidores citoquina.
WO2005029187A1 (en) * 2003-09-22 2005-03-31 Agfa-Gevaert Photopolymerizable composition.
US7097888B2 (en) * 2003-12-15 2006-08-29 Eastman Kodak Company Aligned liquid crystal layer containing azolium salts and process for increasing the tilt
US7592373B2 (en) * 2003-12-23 2009-09-22 Boehringer Ingelheim International Gmbh Amide compounds with MCH antagonistic activity and medicaments comprising these compounds
JP2007525494A (ja) * 2004-02-06 2007-09-06 インサイト バイオファーマシューティカルズ リミテッド ヘパラナーゼ阻害剤及びその使用
MY144903A (en) * 2004-06-17 2011-11-30 Novartis Ag Pyrrolopyridine derivatives and their use as crth2 antagonists
WO2006019270A1 (en) * 2004-08-19 2006-02-23 Lg Chem. Ltd. Organic light-emitting device comprising buffer layer and method for fabricating the same
US7723340B2 (en) * 2005-01-13 2010-05-25 Signal Pharmaceuticals, Llc Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith
MX2007011234A (es) * 2005-03-14 2007-11-12 Transtech Pharma Inc Derivados de benzazol, composiciones y metodos de uso en la forma de inhibidores de b-secretasa.
JP2007086165A (ja) * 2005-09-20 2007-04-05 Fujifilm Corp 感光性組成物、これを用いた平版印刷版原版及び画像記録方法
US8496835B2 (en) * 2005-12-02 2013-07-30 Sachem, Inc. Anion-exchange displacement chromatography process and anionic organic compounds for use as displacer compounds in anion-exchange displacement chromatography process
KR101213485B1 (ko) * 2006-01-27 2012-12-18 삼성디스플레이 주식회사 유기 금속 착물 및 이를 이용한 유기 전계 발광 소자
KR101213486B1 (ko) * 2006-02-02 2012-12-20 삼성디스플레이 주식회사 유기 금속 착물 및 이를 이용한 유기 전계 발광 소자
US8518980B2 (en) * 2006-02-10 2013-08-27 Summit Corporation Plc Treatment of Duchenne muscular dystrophy
KR101325062B1 (ko) * 2006-05-19 2013-11-05 삼성디스플레이 주식회사 발광 이종 핵 구리-이리듐 착체 및 이를 이용한 유기 전계발광 소자

Similar Documents

Publication Publication Date Title
JP2009541403A5 (enExample)
JP2010501534A5 (enExample)
JP2010507682A5 (enExample)
JP2009149903A5 (enExample)
JP2008506632A5 (enExample)
JP2011508438A5 (enExample)
JP2009535462A5 (enExample)
JP2011518833A5 (enExample)
JP2009524695A5 (enExample)
IL191699A0 (en) N-(5-membered heteroaromatic ring)-amido anti-viral compounds
JP2016504351A5 (enExample)
WO2007087416A3 (en) Methods of increasing oral bioavailability of tetracyclines
JP2013500200A5 (enExample)
JP2009544651A5 (enExample)
JP2013532130A5 (enExample)
JP2013521273A5 (enExample)
EP2146979A4 (en) NOVEL PROCESS FOR THE MANUFACTURE OF 2-HYDROXY-3- [5- (MORPHOLIN-4-YLMETHYL) PYRIDIN-2-YL] 1H-INDOLE-5-CARBONITRILE 701
JP2008266364A5 (enExample)
JP2022538215A5 (enExample)
SI2152670T1 (sl) Premoščene šestčlenske obročne spojine
WO2009021748A3 (en) Polymorphs of a compound for the treatment of duchenne muscular dystrophy
JP2008248311A5 (enExample)
JP2015506941A5 (enExample)
JP2012513585A5 (enExample)
HUE030263T2 (en) New synthesis for the preparation of thiazolidinedione compounds